Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes

European Journal of Pharmacology

Volumn 585, Issue 1, 2008, Pages 88-96

  Wessels, Alette M ^a   Scheltens, Philip ^a   Barkhof, Frederik ^a   Heine, Robert J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Brain function; Brain structure; Cognitive functioning; Microvascular disease; Type 1 diabetes

Indexed keywords

INSULIN;

BRAIN FUNCTION; COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SEIZURE;

CHRONIC DISEASE; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 1; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; NEUROPSYCHOLOGICAL TESTS; RECURRENCE;

EID: 42249104209     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.11.080     Document Type: Review

References (87)

1. Araki Y., Nomura M., Tanaka H., Yamamoto H., Yamamoto T., Tsukaguchi I., and Nakamura H. MRI of the brain in diabetes mellitus. Neuroradiology 36 (1994) 101-103
2. Bigler E.D., Lowry C.M., Kerr B., Tate D.F., Hessel C.D., Earl H.D., Miller M.J., Rice S.A., Smith K.H., Tschanz J.T., Welsh-Bohmer K., Plassman B., and Victoroff J. Role of white matter lesions, cerebral atrophy, and APOE on cognition in older persons with and without dementia: the Cache County, Utah, study of memory and aging. Neuropsychology 17 (2003) 339-352
3. Brands A.M., Biessels G.J., de Haan E.H., Kappelle L.J., and Kessels R.P. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28 (2005) 726-735
4. Burton E.J., Kenny R.A., O'Brien J., Stephens S., Bradbury M., Rowan E., Kalaria R., Firbank M., Wesnes K., and Ballard C. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke 35 (2004) 1270-1275
5. Chabriat H., Sachon C., Levasseur M., Grimaldi A., Pappata S., Rougemont D., Masure M.C., De Recondo A., and Samson Y. Brain metabolism after recurrent insulin induced hypoglycaemic episodes: a PET study. J. Neurol. Neurosurg. Psychiatry 57 (1994) 1360-1365
6. Cox D.J., Gonder-Frederick L.A., Schroeder D.B., Cryer P.E., and Clarke W.L. Disruptive effects of acute hypoglycemia on speed of cognitive and motor performance. Diabetes Care 16 (1993) 1391-1393
7. Cox D.J., Kovatchev B.P., Gonder-Frederick L.A., Summers K.H., McCall A., Grimm K.J., and Clarke W.L. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 28 (2005) 71-77
8. Cranston I., Reed L.J., Marsden P.K., and Amiel S.A. Changes in regional brain (18)F fluorodeoxyglucose uptake at hypoglycemia in type 1 diabetic men associated with hypoglycemia unawareness and counter-regulatory failure. Diabetes 50 (2001) 2329-2336
9. De Groot J.C., de Leeuw F.E., Oudkerk M., van Gijn J., Hofman A., Jolles J., and Breteler M.M. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann. Neurol. 47 (2000) 145-151
10. De Jong r. The nervous system complications in diabetes mellitus with special reference to cerebrovascular changes. J. Nerv. Ment. Dis. 111 (1950) 181-206
11. De la Torre J.C., and Mussivand T. Can disturbed brain microcirculation cause Alzheimer's disease?. Neurol. Res. 15 (1993) 146-153
12. Deary I.J., Crawford J.R., Hepburn D.A., Langan S.J., Blackmore L.M., and Frier B.M. Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 42 (1993) 341-344
13. Deary I.J., Sommerfield A.J., McAulay V., and Frier B.M. Moderate hypoglycaemia obliterates working memory in humans with and without insulin treated diabetes. J. Neurol. Neurosurg. Psychiatry 74 (2003) 278-279
14. DeCarli C., Murphy D.G., Tranh M., Grady C.L., Haxby J.V., Gillette J.A., Salerno J.A., Gonzales-Aviles A., Horwitz B., Rapoport S.I., et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 45 (1995) 2077-2084
15. Dejgaard A., Gade A., Larsson H., Balle V., Parving A., and Parving H.H. Evidence for diabetic encephalopathy. Diabet. Med. 8 (1991) 162-167
16. Diabetes Control and Complications Trial Research Group. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann. Intern. Med. 124 (1996) 379-388
17. Dow C., Seidenberg M., and Hermann B. Relationship between information processing speed in temporal lobe epilepsy and white matter volume. Epilepsy Behav. 5 (2004) 919-925
18. Draelos M.T., Jacobson A.M., Weinger K., Widom B., Ryan C.M., Finkelstein D.M., and Simonson D.C. Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. Am. J. Med. 98 (1995) 135-144
19. Fanelli C.G., Paramore D.S., Hershey T., Terkamp C., Ovalle F., Craft S., and Cryer P.E. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes 47 (1998) 1920-1927
20. Farkas E., and Luiten P.G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64 (2001) 575-611
21. Fazekas F., Kleinert R., Offenbacher H., Schmidt R., Kleinert G., Payer F., Radner H., and Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43 (1993) 1683-1689
22. Ferguson S.C., Blane A., Perros P., McCrimmon R.J., Best J.J., Wardlaw J., Deary I.J., and Frier B.M. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 52 (2003) 149-156
23. Ferguson S.C., Blane A., Wardlaw J., Frier B.M., Perros P., McCrimmon R.J., and Deary I.J. Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care 28 (2005) 1431-1437
24. Filley C. The behavioral neurology of white matter (2001), Oxford University Press, New York
25. Fulesdi B., Limburg M., Bereczki D., Michels R.P., Neuwirth G., Legemate D., Valikovics A., and Csiba L. Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes 46 (1997) 1840-1845
26. Gold A.E., Deary I.J., MacLeod K.M., Thomson K.J., and Frier B.M. Cognitive function during insulin-induced hypoglycemia in humans: short-term cerebral adaptation does not occur. Psychopharmacology (Berl) 119 (1995) 325-333
27. Greene D.A., Lattimer S.A., and Sima A.A. Sorbitol, phosphoinositides, and sodium potassium-ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 316 (1987) 599-606
28. Gunning-Dixon F.M., and Raz N. Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study. Neuropsychologia 41 (2003) 1929-1941
29. Jacobson A.M., Musen G., Ryan C.M., Silvers N., Cleary P., Waberski B., Burwood A., Weinger K., Bayless M., Dahms W., and Harth J. Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med. 356 (2007) 1842-1852
30. Johnson P.C., Brendel K., and Meezan E. Thickened cerebral cortical capillary basement membranes in diabetics. Arch. Pathol. Lab. Med. 106 (1982) 214-217
31. Kalaria R.N., and Hedera P. Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuroreport 6 (1995) 477-480
32. Kaplan J.G., Katzman R., Horoupian D.S., Fuld P.A., Mayeux R., and Hays A.P. Progressive dementia, visual deficits, amyotrophy, and microinfarcts. Neurology 35 (1985) 789-796
33. Kawamura J., Meyer J.S., Terayama Y., and Weathers S. Leukoaraiosis correlates with cerebral hypoperfusion in vascular dementia. Stroke 22 (1991) 609-614
34. Keymeulen B., Jacobs A., de Metz K., de Sadeleer C., Bossuyt A., and Somers G. Regional cerebral hypoperfusion in long-term type 1 (insulin-dependent) diabetic patients: relation to hypoglycaemic events. Nucl. Med. Commun. 16 (1995) 10-16
35. Kobari M., Meyer J.S., and Ichijo M. Leuko-araiosis, cerebral atrophy, and cerebral perfusion in normal aging. Arch. Neurol. 47 (1990) 161-165
36. Kovari E., Gold G., Herrmann F.R., Canuto A., Hof P.R., Michel J.P., Bouras C., and Giannakopoulos P. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 35 (2004) 410-414
37. Kuhl D.E., Metter E.J., Riege W.H., and Hawkins R.A. The effect of normal aging on patterns of local cerebral glucose utilization. Ann. Neurol. 15 Suppl (1984) S133-S137
38. Langan S.J., Deary I.J., Hepburn D.A., and Frier B.M. Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia 34 (1991) 337-344
39. Lincoln N.B., Faleiro R.M., Kelly C., Kirk B.A., and Jeffcoate W.J. Effect of long-term glycemic control on cognitive function. Diabetes Care 19 (1996) 656-658
40. Lunetta M., Damanti A.R., Fabbri G., Lombardo M., Di Mauro M., and Mughini L. Evidence by magnetic resonance imaging of cerebral alterations of atrophy type in young insulin-dependent diabetic patients. J. Endocrinol. Investig. 17 (1994) 241-245
41. MacLeod K.M., Hepburn D.A., Deary I.J., Goodwin G.M., Dougall N., Ebmeier K.P., and Frier B.M. Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia. Diabetologia 37 (1994) 257-263
42. MacLeod K.M., Gold A.E., Ebmeier K.P., Hepburn D.A., Deary I.J., Goodwin G.M., and Frier B.M. The effects of acute hypoglycemia on relative cerebral blood flow distribution in patients with type I (insulin-dependent) diabetes and impaired hypoglycemia awareness. Metabolism 45 (1996) 974-980
43. Maran A., Lomas J., Macdonald I.A., and Amiel S.A. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM. Diabetologia 38 (1995) 1412-1418
44. Marchal G., Rioux P., Petit-Taboue M.C., Sette G., Travere J.M., Le Poec C., Courtheoux P., Derlon J.M., and Baron J.C. Regional cerebral oxygen consumption, blood flow, and blood volume in healthy human aging. Arch. Neurol. 49 (1992) 1013-1020
45. McAulay V., Deary I.J., Ferguson S.C., and Frier B.M. Acute hypoglycemia in humans causes attentional dysfunction while nonverbal intelligence is preserved. Diabetes Care 24 (2001) 1745-1750
46. Mielke R., Herholz K., Grond M., Kessler J., and Heiss W.D. Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch. Neurol. 49 (1992) 909-913
47. Mijnhout G.S., Scheltens P., Diamant M., Biessels G.J., Wessels A.M., Simsek S., Snoek F.J., and Heine R.J. Diabetic encephalopathy: a concept in need of a definition. Diabetologia 49 (6) (2006) 1447-1448
48. Miles W., and Root F. Psychologic tests applied to diabetic patients. Arch. Intern. Med. 30 (1922) 769-777
49. Munoz D.G. The pathological basis of multi-infarct dementia. Alzheimer Dis. Assoc. Disord. 5 (1991) 77-90
50. Musen G., Lyoo I.K., Sparks C.R., Weinger K., Hwang J., Ryan C.M., Jimerson D.C., Hennen J., Renshaw P.F., and Jacobson A.M. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55 (2006) 326-333
51. Northam E.A., Rankins D., and Cameron F.J. Therapy insight: the impact of type 1 diabetes on brain development and function. Nat. Clin. Pract. Neurol. 2 (2006) 78-86
52. Perantie D.C., Wu J., Koller J.M., Lim A., Warren S.L., Black K.J., Sadler M., White N.H., and Hershey T. Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care (2007) 10.1111/j.1399-5448.2007.00274.x
53. Perros P., Deary I.J., Sellar R.J., Best J.J., and Frier B.M. Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20 (1997) 1013-1018
54. Reichard P., Berglund B., Britz A., Cars I., Nilsson B.Y., and Rosenqvist U. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J. Intern. Med. 230 (1991) 101-108
55. Reiche W., Weiller C., Weigmann R., Kaiser H.J., Bull U., Schneider R., and Ringelstein E.B. A comparison of MRT and SPECT findings in patients with cerebral microangiopathy. Nuklearmedizin 30 (1991) 161-169
56. Reske-Nielsen E., Lundbaek K., and Rafaelsen O.J. Pathological changes in the central and peripheral nervous system of young longterm diabetics. Diabetologia 1 (1965) 233-241
57. Rovet J.F., and Ehrlich R.M. The effect of hypoglycemic seizures on cognitive function in children with diabetes: a 7-year prospective study. J. Pediatr. 134 (1999) 503-506
58. Ryan C.M. Diabetes, aging, and cognitive decline. Neurobiol. Aging 26 Suppl 1 (2005) 21-25
59. Ryan C.M. Why is cognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis. Pediatr. Diabetes 7 (2006) 289-297
60. Ryan C.M., Williams T.M., Orchard T.J., and Finegold D.N. Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes 41 (1992) 107-113
61. Ryan C.M., Geckle M.O., and Orchard T.J. Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications. Diabetologia 46 (2003) 940-948
62. Sabri O., Ringelstein E.B., Hellwig D., Schneider R., Schreckenberger M., Kaiser H.J., Mull M., and Buell U. Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke 30 (1999) 556-566
63. Sabri O., Hellwig D., Schreckenberger M., Schneider R., Kaiser H.J., Wagenknecht G., Mull M., and Buell U. Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow. Nucl. Med. Common. 21 (2000) 19-29
64. Salem M.A., Matta L.F., Tantawy A.A., Hussein M., and Gad G.I. Single photon emission tomography (SPECT) study of regional cerebral blood flow in normoalbuminuric children and adolescents with type 1 diabetes. Pediatr. Diabetes 3 (2002) 155-162
65. Sanfilipo M.P., Benedict R.H., Weinstock-Guttman B., and Bakshi R. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 66 (2006) 685-692
66. Schoenle E.J., Schoenle D., Molinari L., and Largo R.H. Impaired intellectual development in children with Type I diabetes: association with HbA(1c), age at diagnosis and sex. Diabetologia 45 (2002) 108-114
67. Segel S.A., Fanelli C.G., Dence C.S., Markham J., Videen T.O., Paramore D.S., Powers W.J., and Cryer P.E. Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia. Diabetes 50 (2001) 1911-1917
68. Smith C.D., Snowdon D.A., Wang H., and Markesbery W.R. White matter volumes and periventricular white matter hyperintensities in aging and dementia. Neurology 54 (2000) 838-842
69. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., and Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. Jama 277 (1997) 813-817
70. Sokoloff L. Relation between physiological function and energy metabolism in the central nervous system. J. Neurochem. 29 (1977) 13-26
71. Sommerfield A.J., Deary I.J., McAulay V., and Frier B.M. Short-term, delayed, and working memory are impaired during hypoglycemia in individuals with type 1 diabetes. Diabetes Care 26 (2003) 390-396
72. Strachan M.W., Deary I.J., Ewing F.M., and Frier B.M. Recovery of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes. Diabetes Care 23 (2000) 305-312
73. Tallroth G., Ryding E., and Agardh C.D. The influence of hypoglycaemia on regional cerebral blood flow and cerebral volume in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36 (1993) 530-535
74. Tomlinson B.E., Blessed G., and Roth M. Observations on the brains of demented old people. J. Neurol. Sci. 11 (1970) 205-242
75. Tullberg M., Fletcher E., DeCarli C., Mungas D., Reed B.R., Harvey D.J., Weiner M.W., Chui H.C., and Jagust W.J. White matter lesions impair frontal lobe function regardless of their location. Neurology 63 (2004) 246-253
76. Wen W., Sachdev P.S., Chen X., and Anstey K. Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample. Neuroimage 29 (2006) 1031-1039
77. Wessels A.M., Rombouts S.A., Simsek S., Kuijer J.P., Kostense P.J., Barkhof F., Scheltens P., Snoek F.J., and Heine R.J. Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study. Diabetes 55 (2006) 334-340
78. Wessels A.M., Simsek S., Remijnse P.L., Veltman D.J., Biessels G.J., Barkhof F., Scheltens P., Snoek F.J., Heine R.J., and Rombouts S.A. Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 49 (2006) 2474-2480
79. Wessels A.M., Rombouts S.A., Remijnse P.L., Boom Y., Scheltens P., Barkhof F., Heine R.J., and Snoek F.J. Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume. Diabetologia 50 (2007) 1763-1769
80. Wong T.Y., Klein R., Couper D.J., Cooper L.S., Shahar E., Hubbard L.D., Wofford M.R., and Sharrett A.R. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 358 (2001) 1134-1140
81. Wong T.Y., Klein R., Klein B.E., Tielsch J.M., Hubbard L., and Nieto F.J. Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv. Ophthalmol. 46 (2001) 59-80
82. Wong T.Y., Klein R., Sharrett A.R., Couper D.J., Klein B.E., Liao D.P., Hubbard L.D., and Mosley T.H. Cerebral white matter lesions, retinopathy, and incident clinical stroke. Jama 288 (2002) 67-74
83. Wredling R., Levander S., Adamson U., and Lins P.E. Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man. Diabetologia 33 (1990) 152-157
84. Yamaguchi T., Kanno I., Uemura K., Shishido F., Inugami A., Ogawa T., Murakami M., and Suzuki K. Reduction in regional cerebral metabolic rate of oxygen during human aging. Stroke 17 (1986) 1220-1228
85. Yao H., Sadoshima S., Kuwabara Y., Ichiya Y., and Fujishima M. Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type. Stroke 21 (1990) 1694-1699
86. Ylikoski A., Erkinjuntti T., Raininko R., Sarna S., Sulkava R., and Tilvis R. White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 26 (1995) 1171-1177
87. Zivadinov R., Sepcic J., Nasuelli D., De Masi R., Bragadin L.M., Tommasi M.A., Zambito-Marsala S., Moretti R., Bratina A., Ukmar M., Pozzi-Mucelli R.S., Grop A., Cazzato G., and Zorzon M. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 70 (2001) 773-780